Becton, Dickinson and Company: Constriction, Pathologic trials

The registry lists 10 Constriction, Pathologic studies with Becton, Dickinson and Company as lead sponsor. 0 are open to participants now and 8 have results posted.

Phase 2 1Phase 3 1No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Lutonix Drug Coated Balloon for Treatment of Femoropopliteal Arteries in United States Females (CONFIRM)TerminatedNCT02813577Not applicableResults posted
• Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft in AV Graft Patients (AVeVA)CompletedNCT02790606Not applicableResults posted
• Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent GraftCompletedNCT02649946Not applicableResults posted
• Moxy Drug Coated Balloon vs. Standard Balloon Angioplasty for the Treatment of Femoropopliteal ArteriesCompletedNCT01412541Not applicableResults posted
• Pivotal Study for the FLAIR Endovascular Stent GraftCompletedNCT00678249Not applicableResults posted
• Post-Approval Study for the FLAIR Endovascular Stent GraftCompletedNCT00677235Not applicableResults posted
• FLAIR™ Delivery System StudyCompletedNCT00614315Not applicableResults posted
• ViVEXX Carotid Revascularization Trial (VIVA)CompletedNCT00417963Phase 3Results posted
• A Single Arm Trial Evaluating the BARD Lutonix Drug-Coated Balloon (LTX DCB) for Treatment of Femoropopliteal ArteriesCompletedNCT02720003Not applicable
• LEVANT Japan Clinical TrialCompletedNCT01816412Phase 2